Investors looking for growth opportunities in the healthcare sector may find Amneal Pharmaceuticals, Inc. (NYSE: AMRX) an intriguing candidate. This global biopharmaceutical company, with a market cap of $4.33 billion,..
Zai Lab Limited (NASDAQ: ZLAB), a leading biopharmaceutical company based in China, stands at a pivotal moment in its journey. With an impressive market cap of $2.06 billion, Zai Lab..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is steadily carving its niche in the healthcare sector, specifically within the medical devices industry. Headquartered in San Jose, California, the company focuses on innovative..
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, is capturing investor interest with its promising potential upside of 19.63%. Headquartered in Edmonton, Canada, Aurinia is dedicated..
Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, operates within the medical care facilities industry, focusing on long-term health care facilities (LTCFs) across the United..
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Founded in 2014 and headquartered in Kirkland, Washington, Kestra..
U.S. Physical Therapy, Inc. (NYSE: USPH) has been garnering attention among investors, particularly those with an interest in the healthcare sector. With a market capitalization of $1.26 billion, this Houston-based..
AdaptHealth Corp. (NASDAQ: AHCO) stands as a significant player in the U.S. healthcare landscape, operating within the medical devices industry. Despite facing certain operational challenges, the company offers intriguing potential..
Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors as it navigates the complexities of vaccine development and commercialization. With a market..
Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its diverse portfolio focused on food and animal safety products...
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to physician enablement and a promising potential..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a dynamic player in the biotechnology sector, headquartered in Cambridge, Massachusetts. The company is renowned for its innovative approach to developing therapies in the..
Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology sector with its innovative approach to addressing serious and rare diseases. With a market capitalization of..
Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor interest with its significant growth potential in the biotechnology sector. The company, with its $4.44 billion market cap, is a clinical-stage biopharmaceutical..
Evotec SE (EVO) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, specifically within drug manufacturing. Headquartered in Hamburg, Germany, Evotec operates in both..
Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector with a robust focus on vaccine development and commercialization. As a commercial-stage biopharmaceutical company, Dynavax has carved a..
Pulse Biosciences, Inc (NASDAQ: PLSE), a burgeoning player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative bioelectric medicine technologies. Headquartered in..
Progyny, Inc. (NASDAQ: PGNY), a healthcare plans company specializing in fertility and family-building benefits, is drawing attention with a notable potential upside of 68.39%, according to current analyst ratings. As..
Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company strategically positioned in the healthcare sector, is catching the eye of investors with a striking potential upside of 94.88%. Despite a modest..
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining traction among investors as a promising player in the biotechnology sector. With a current market cap of $2.9 billion, this precision medicine oncology..
